105 related articles for article (PubMed ID: 22677767)
1. [Changes in the hemostasis system and free-radical lipid oxidation in the acute stage of ischemic stroke in patients on neuroprotection treatment].
Izhbul'dina GI
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 2):31-7. PubMed ID: 22677767
[TBL] [Abstract][Full Text] [Related]
2. [Correction of free-radical oxidation as a pathogenetic approach to the treatment of acute ischemic stroke].
Chugunov AV; Kamchatnov PR; Mikhaĭlova NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10 Suppl 2):65-8. PubMed ID: 20229636
[TBL] [Abstract][Full Text] [Related]
3. [Optimization of hypolipidemic therapy in patients with ischemic stroke and diabetes mellitus].
Shchepankevich LA; Nikolaev YA; Dolgova NA; Chipova DT
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2):42-45. PubMed ID: 27029446
[TBL] [Abstract][Full Text] [Related]
4. [The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke].
Odinak MM; Ianishevskiĭ SN; Tsygan NV; Golokhvastov SIu; Vozniuk IA; Trufanov AG
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12 Pt 2):55-60. PubMed ID: 24430036
[TBL] [Abstract][Full Text] [Related]
5. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of free radical processes in acute ischemic stroke: influence on neurological status and outcome.
Alexandrova M; Bochev P; Markova V; Bechev B; Popova M; Danovska M; Simeonova V
J Clin Neurosci; 2004 Jun; 11(5):501-6. PubMed ID: 15177393
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of the efficacy of mexidol in the combination with hyperbaric oxygen in acute ischemic stroke].
Kulai NS; Kovalchuk EY
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3. Vyp. 2):69-72. PubMed ID: 29798984
[TBL] [Abstract][Full Text] [Related]
8. [The use of mexidol in acute period of ischemic stroke].
Novikova LB; Sarafutdinova LR; Sharapova KM
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):83-5. PubMed ID: 24107887
[No Abstract] [Full Text] [Related]
9. [The efficacy of mexidol for transient ischemic attacks in the vertebrobasilar system in elderly patients with chronic cerebral ischemia].
Abramenko YV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9. Vyp. 2):42-48. PubMed ID: 30499559
[TBL] [Abstract][Full Text] [Related]
10. Danqi Piantan Jiaonang does not modify hemostasis, hematology, and biochemistry in normal subjects and stroke patients.
Gan R; Lambert C; Lianting J; Chan ES; Venketasubramanian N; Chen C; Chan BP; Samama MM; Bousser MG
Cerebrovasc Dis; 2008; 25(5):450-6. PubMed ID: 18417963
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke].
Chefranova ZhIu; Makotrova TA; Udachin VA; Koledintseva EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):49-52. PubMed ID: 22810741
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
Strelnikova IA; Svetkina AA; Androfagina OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
[TBL] [Abstract][Full Text] [Related]
13. Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin.
Lampl Y; Lorberboym M; Gilad R; Vysberg I; Tikozky A; Sadeh M; Boaz M
Clin Neuropharmacol; 2010 May; 33(3):129-34. PubMed ID: 20502132
[TBL] [Abstract][Full Text] [Related]
14. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
Abramenko IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
Berezhnaya SV; Yakupov EZ; Zaharov YA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of patients with ishemic stroke in the vertebral-basilar system in acute period: experience of using the neuroprotective drug Mexidol].
Goncharova ZA; Chernikova IV; Nazarova VA; Tolmacheva VV; Ovsepian KG
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):78-84. PubMed ID: 38465813
[TBL] [Abstract][Full Text] [Related]
17. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and immunobiochemical study of efficacy and stress-protective properties of thyroliberin at the acute stage of carotid ischemic stroke].
Skvortsova VI; Platonova IA; Shamalov NA; Polepchuk AN; Maslak AA; Arsen'eva EL; Grivennikov IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():51-9. PubMed ID: 18196636
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol for the prevention of acute progressing stroke: a multicenter, randomized controlled trial.
Shimizu H; Tominaga T; Ogawa A; Kayama T; Mizoi K; Saito K; Terayama Y; Ogasawara K; Mori E;
J Stroke Cerebrovasc Dis; 2013 May; 22(4):449-56. PubMed ID: 23541423
[TBL] [Abstract][Full Text] [Related]
20. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
